Zhu, Xiao-Hui

Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models. [electronic resource] - Food & function Apr 2019 - 2040-2049 p. digital

Publication Type: Journal Article

2042-650X

10.1039/c8fo01756e doi


Animals
Chloride Channels--genetics
Colonic Neoplasms--drug therapy
Disease Models, Animal
Disease Progression
Drug Synergism
Flavonols--administration & dosage
Humans
Irinotecan--administration & dosage
Male
Mice
Mice, Inbred C57BL
Mitochondrial Proteins--genetics